AI-powered diagnostic imaging for wound care treatment decisions
Spectral AI develops a predictive diagnostic device (DeepView®) using machine learning to assess wound healing potential before clinical intervention. The tech stack—PyTorch, TensorFlow, CUDA, ONNX Runtime—reflects a mature ML infrastructure; concurrent work on SBOM creation, vulnerability scanning, and embedded cybersecurity signals a company scaling through regulatory and supply-chain maturity, not just model performance. Hiring is engineering-heavy (9 roles) with a steep intern-to-senior ratio, indicating rapid onboarding alongside retention challenges typical of pre-market medical-device firms.
Spectral AI is a Dallas-based public company building DeepView®, a predictive diagnostic system for wound care—initially focused on burn assessment. The platform uses algorithm-driven image analysis to give clinicians objective, real-time insight into a wound's healing trajectory, aiming to accelerate treatment decisions and reduce costs. The company operates across medical imaging, embedded systems, and cloud infrastructure (AWS, GCP, Azure), with active work on fixture design, system-level performance testing, and clinical software integration. Current operations span 51–200 employees across engineering, data science, and research; hiring is concentrated in the U.S. and accelerating.
PyTorch and TensorFlow are the primary frameworks, deployed via ONNX Runtime and TensorRT for inference acceleration on medical imaging hardware.
Dallas, TX. The company is a public firm with 51–200 employees, all hiring currently in the United States.
Other companies in the same industry, closest in size